Factors that Affect the Osteoclastogenesis of RAW264.7 Cells
暂无分享,去创建一个
[1] K. Ochiai,et al. BIX01294 suppresses osteoclast differentiation on mouse macrophage-like Raw264.7 cells. , 2013, Bosnian journal of basic medical sciences.
[2] H. Aburatani,et al. Metabolic regulation of osteoclast differentiation and function , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] Mahmoud M. Bakr,et al. Foreign body giant cells and osteoclasts are TRAP positive, have podosome‐belts and both require OC‐STAMP for cell fusion , 2013, Journal of cellular biochemistry.
[4] Z. Gu,et al. BMP2/7 heterodimer can modulate all cellular events of the in vitro RANKL-mediated osteoclastogenesis, respectively, in different dose patterns. , 2012, Tissue engineering. Part A.
[5] P. Collin‐Osdoby,et al. RANKL-mediated osteoclast formation from murine RAW 264.7 cells. , 2012, Methods in molecular biology.
[6] A. Nohe,et al. Bone morphogenetic proteins: a critical review. , 2011, Cellular signalling.
[7] J. Westendorf,et al. Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors , 2010, Journal of cellular biochemistry.
[8] E. Bradley,et al. Osteoclast culture and resorption assays. , 2008, Methods in molecular biology.
[9] N. Udagawa,et al. Generation of osteoclasts in vitro, and assay of osteoclast activity. , 2007, Methods in molecular medicine.
[10] H. Blair,et al. Negative Regulation of RANKL-induced Osteoclastic Differentiation in RAW264.7 Cells by Estrogen and Phytoestrogens* , 2005, Journal of Biological Chemistry.
[11] L. Filgueira,et al. Fluorescence-based Staining for Tartrate-resistant Acidic Phosphatase (TRAP) in Osteoclasts Combined with Other Fluorescent Dyes and Protocols , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[12] Noriaki Yoshida,et al. U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells* , 2002, The Journal of Biological Chemistry.
[13] S. Morony,et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] N. Udagawa,et al. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. , 1999, Biochemical and biophysical research communications.
[15] Sheila J. Jones,et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] A. Hollander,et al. Molecular Interaction and Matrix Assembly , 1998, The Biochemical journal.
[17] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[18] G. Wogan,et al. Growth and viability of macrophages continuously stimulated to produce nitric oxide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] B. Gelb,et al. Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency , 1996, Science.
[20] I. Marison,et al. The importance of ammonia in mammalian cell culture. , 1996, Journal of biotechnology.
[21] I. James,et al. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[22] N. Udagawa,et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. , 1993, The Journal of clinical investigation.
[23] J. Quinn,et al. Bone resorption by macrophage polykaryons of a pilar tumor of scalp. , 1992, Cancer.
[24] S. Niida,et al. BriefDefinitive Report Essential Role of Macrophage Colony-Stimulating Factor in the Osteoclast Differentiation Supported by , 2022 .
[25] J. McGee,et al. Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath. , 1991, British Journal of Cancer.
[26] N. Athanasou,et al. Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. , 1990, Journal of clinical pathology.
[27] B Crabtree,et al. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells , 1985, Bioscience reports.
[28] P. Ralph,et al. Functional macrophage cell lines transformed by abelson leukemia virus , 1978, Cell.
[29] P. Ralph,et al. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. , 1977, Journal of immunology.
[30] L. Levintow,et al. The role of glutamine in protein biosynthesis in tissue culture. , 1957, The Journal of biological chemistry.